A New Hope in Breast Cancer Treatment: The Power of ErSO-TFPy
Breast cancer is one of the leading causes of cancer-related deaths worldwide, with over 250,000 new cases annually in the U.S. alone. Among these, estrogen receptor alpha-positive (ERα+) breast cancer accounts for approximately 70% of cases. Despite advances in treatment, challenges like prolonged therapies, side effects, and resistance remain significant hurdles for patients and healthcare … Read more